Project A Multicenter, Randomized, Double-Blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory…

Basic data

Title:
A Multicenter, Randomized, Double-Blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory Differentiated Thyroid Cancer
Duration:
07/03/2016 to 06/03/2020
Abstract / short description:
protocol number E7080-G000-211 entitled “A Multicenter, Randomized, Double-Blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory Differentiated Thyroid Cancer
Keywords:
clinical trial
klinische Studie

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Nuclear Medicine and Clinical Molecular Imaging
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Frankfurt am Main, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.